Page last updated: 2024-08-25

7-hydroxystaurosporine and Carcinoma, Anaplastic

7-hydroxystaurosporine has been researched along with Carcinoma, Anaplastic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, T; Berchuck, A; Cory Barnett, J; Fujii, S; Kondoh, E; Konishi, I; Matsumura, N; Mori, S; Murphy, SK; Whitaker, RS; Yamaguchi, K1
Bozko, P; Larsen, AK; Raymond, E; Skladanowski, A1
Bhonde, MR; Daniel, PT; Hanski, C; Hanski, ML; Kohno, K; Magrini, R; Moorthy, D; Müller, A; Sausville, EA; Wiegand, P; Zeitz, M1
Daoud, SS; Mixter, P; Redkar, A1
Kaur, G; Sausville, EA; Sebers, S; Seynaeve, CM; Stetler-Stevenson, M; Worland, PJ1
Abe, S; Furukawa, T; Kitajima, M; Kubota, T; Kumai, K; Otani, Y; Watanabe, M1

Other Studies

6 other study(ies) available for 7-hydroxystaurosporine and Carcinoma, Anaplastic

ArticleYear
Targeting slow-proliferating ovarian cancer cells.
    International journal of cancer, 2010, May-15, Volume: 126, Issue:10

    Topics: Antineoplastic Agents; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Disease-Free Survival; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen; Ovarian Neoplasms; Protein Kinase C; Protein Kinase Inhibitors; Staurosporine

2010
Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.
    Acta biochimica Polonica, 2002, Volume: 49, Issue:1

    Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma; Cell Cycle; Colonic Neoplasms; Etoposide; Humans; Staurosporine; Topoisomerase Inhibitors; Tumor Suppressor Protein p53

2002
The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein.
    Oncogene, 2005, Jan-06, Volume: 24, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma; Colonic Neoplasms; Cyclin-Dependent Kinases; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; NF-kappa B; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Staurosporine; Trans-Activators; Tumor Cells, Cultured

2005
Implications of p53 in growth arrest and apoptosis on combined treatment of human Mammary epithelial cells with topotecan and UCN-01.
    Journal of experimental therapeutics & oncology, 2004, Volume: 4, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Carcinoma; Cell Cycle; Cell Proliferation; Epithelial Cells; Female; Genes, p53; Humans; Staurosporine; Topotecan; Tumor Cells, Cultured

2004
Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.
    Cancer research, 1993, May-01, Volume: 53, Issue:9

    Topics: Alkaloids; Breast Neoplasms; Carcinoma; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Flow Cytometry; Growth Inhibitors; Humans; In Vitro Techniques; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Staurosporine; Time Factors; Tumor Cells, Cultured; Tyrosine

1993
UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Japanese journal of cancer research : Gann, 2000, Volume: 91, Issue:11

    Topics: Alkaloids; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Staurosporine; Thymidylate Synthase; Tumor Cells, Cultured

2000